Scientists seek to unravel FOXP1's role in autism and development

NCT ID NCT03718923

Recruiting now Knowledge-focused Sponsor: Icahn School of Medicine at Mount Sinai Source: ClinicalTrials.gov ↗

First seen May 30, 2026 · Last updated Jun 16, 2026 · Updated 1 time

Summary

This study aims to learn more about how changes in the FOXP1 gene affect development, language, and behavior in children and adults. Researchers will use interviews, play-based assessments, and genetic tests to better understand these rare conditions. The study is open to people aged 2 and older who have a confirmed FOXP1 gene change. No treatment is given; the goal is to gather information to help future research.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for AUTISM SPECTRUM DISORDER are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Show contact details

Study contacts

Contact

Phone: •••-•••-•••• Email: •••••@•••••
Contact

Phone: •••-•••-•••• Email: •••••@•••••

Locations

The Seaver Autism Center for Research and Treatment
RECRUITING

New York, New York, 10029, United States

Contact Phone: •••-•••-•••• Email: •••••@•••••

Contact Phone: •••-•••-•••• Email: •••••@•••••

Conditions

Explore the condition pages connected to this study.

AUTISM SPECTRUM DISORDER FOXP1 MENTAL RETARDATION WITH LANGUAGE IMPAIRMENT AND WITH OR WITHOUT AUTISTIC FEATURES

Conditions inferred from the trial description

These were inferred from the trial's summary, not listed by the trial registrant.